BioSpace News Archive

Traditions Health, LLC announced that Ronda Van Meter has been named Chief Operating Officer of the organization.

Two of Thorne’s team of highly respected scientific pioneers will be among the featured speakers on February 8-10, at the Medical Fitness Tour conference at the University of California, Irvine.

Lupin is pleased to announce that NaMuscla® (mexiletine) has been launched in Germany and the United Kingdom (UK).

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system disorders (CNS), announces the acquisition of Farmax, a CNS specialty pharmaceutical company, from SVUS Pharma.

Cresco Labs (CSE: CL) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced that the Company’s FloraMedex dispensary launched Illinois’ Opioid Alternative Pilot Program (OAPP) today vastly expanding the population of Illinois patients who can access medical cannabis in place of pharmaceutical opioid medications.

The American Society for Blood and Marrow Transplantation (ASBMT) released a paper on chimeric antigen receptor T cell therapy that proposes a new consensus grading scale for toxicities to be applied across clinical trials, academic research and commercial product development.

If Approved, AJOVY will be the First and Only Anti-CGRP Treatment with Quarterly and Monthly Dosing Options in the European Union

CTI BioPharma Corp. announced that the Company will withdraw its European Marketing Authorization Application for pacritinib as a treatment for myelofibrosis.

Mobile Robot Platforms, Shuttle Automated Storage and Retrieval Systems, Industrial Robotic Manipulators, and Gantry Robots Are All Driving Market Growth

Leading, global healthcare investor and experienced industry executive partner to establish new autism services company